Skip to search formSkip to main contentSkip to account menu

galactoxylomannan

Known as: galactomannoxylan 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The capsular polysaccharides of Cryptococcus neoformans have historically been divided into three components namely… 
Highly Cited
2008
Highly Cited
2008
The effects of capsular polysaccharides, galactoxylomannan (GalXM) and glucuronoxylomannan (GXM), from acapsular (GXM negative… 
2008
2008
ABSTRACT Cryptococcus neoformans capsular polysaccharide is composed of at least two components, glucuronoxylomannan (GXM) and… 
Highly Cited
2006
Highly Cited
2006
The major virulence factor of Cryptococcus neoformans is its polysaccharide capsule composed of glucuronoxylomannan (GXM… 
Highly Cited
2006
Highly Cited
2006
The most distinctive feature of the human pathogenic fungus is a polysaccharide capsule that is essential for virulence and is… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT We report a case of cryptococcosis in which a serum enzyme-linked immunosorbent assay (ELISA) for Aspergillus… 
Highly Cited
1997
Highly Cited
1997
Tumor necrosis factor alpha (TNF-alpha) release by peripheral blood mononuclear cells (PBMC) during disseminated infection by… 
Highly Cited
1997
Highly Cited
1997
CD18, the beta chain of the beta 2 integrin family of adhesion molecules, is associated with three different alpha chains (CD11a… 
Review
1984
Review
1984
Antibodies against the major capsular polysaccharide of Cryptococcus neoformans, glucuronoxylomannan (GXM), and a minor secreted…